Human MASP2/MAP-2/MAP19 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_139208.3)

Cat. No.: pGMPC001363
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human MASP2/MAP-2/MAP19 Non-Viral expression plasmid (overexpression vector) for mouse MASP2 overexpression in unique cell transient transfection and stable cell line development.


Target products collection

Go to MASP2/MAP-2 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMPC001363
Gene Name MASP2
Accession Number NM_139208.3
Gene ID 10747
Species Human
Product Type Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length 558 bp
Gene Alias MAP-2,MAP19,MASP-2,MASP1P1,sMAP
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGAGGCTGCTGACCCTCCTGGGCCTTCTGTGTGGCTCGGTGGCCACCCCCTTGGGCCCGAAGTGGCCTGAACCTGTGTTCGGGCGCCTGGCATCCCCCGGCTTTCCAGGGGAGTATGCCAATGACCAGGAGCGGCGCTGGACCCTGACTGCACCCCCCGGCTACCGCCTGCGCCTCTACTTCACCCACTTCGACCTGGAGCTCTCCCACCTCTGCGAGTACGACTTCGTCAAGCTGAGCTCGGGGGCCAAGGTGCTGGCCACGCTGTGCGGGCAGGAGAGCACAGACACGGAGCGGGCCCCTGGCAAGGACACTTTCTACTCGCTGGGCTCCAGCCTGGACATTACCTTCCGCTCCGACTACTCCAACGAGAAGCCGTTCACGGGGTTCGAGGCCTTCTATGCAGCCGAGGACATTGACGAGTGCCAGGTGGCCCCGGGAGAGGCGCCCACCTGCGACCACCACTGCCACAACCACCTGGGCGGTTTCTACTGCTCCTGCCGCGCAGGCTACGTCCTGCACCGTAACAAGCGCACCTGCTCAGAGCAGAGCCTCTAG
ORF Protein Sequence MRLLTLLGLLCGSVATPLGPKWPEPVFGRLASPGFPGEYANDQERRWTLTAPPGYRLRLYFTHFDLELSHLCEYDFVKLSSGAKVLATLCGQESTDTERAPGKDTFYSLGSSLDITFRSDYSNEKPFTGFEAFYAAEDIDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHRNKRTCSEQSL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-366 Pre-Made Narsoplimab biosimilar, Whole mAb, Anti-MASP2 Antibody: Anti-MAP-2/MAP19/MASP-2/MASP1P1/sMAP therapeutic antibody
    Target Antibody GM-Tg-g-T07448-Ab Anti-MASP2/ MAP19/ MASP-2 functional antibody
    Target Antigen GM-Tg-g-T07448-Ag MASP2 protein
    ORF Viral Vector pGMLP001815 Human MASP2 Lentivirus plasmid
    ORF Viral Vector pGMPC000574 Human MASP2 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector pGMPC001363 Human MASP2 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector pGMPC001388 Human MASP2 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMLP001815 Human MASP2 Lentivirus particle


    Target information

    Target ID GM-T07448
    Target Name MASP2
    Gene Group Identifier
    (Target Gene ID in Homo species)
    10747
    Gene ID 100056770 (Equus caballus), 101099568 (Felis catus), 10747 (Homo sapiens), 17175 (Mus musculus)
    487447 (Canis lupus familiaris), 505819 (Bos taurus), 64459 (Rattus norvegicus), 722714 (Macaca mulatta)
    Gene Symbols & Synonyms MASP2,Masp2,sMAP,MAP-2,MAP19,MASP-2,MASP1P1,MAp19
    Target Alternative Names MAP-2,MAP19,MASP-2,MASP1P1,MASP2,MAp19,MBL-associated serine protease 2,Mannan-binding lectin serine protease 2,Mannose-binding protein-associated serine protease 2 (MASP-2),Masp2,sMAP
    Uniprot Accession O00187,Q91WP0,Q9JJS8
    Additional SwissProt Accessions: O00187,Q91WP0,Q9JJS8
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Therapeutics Target, INN Index
    Disease Acute appendicitis, Dent disease, Contrast - Induced Nephropathy, Congenital occlusion of ureteropelvic junction, Type 2 diabetes mellitus with diabetic nephropathy
    Disease from KEGG Complement and coagulation cascades, Staphylococcus aureus infection
    Gene Ensembl ENSECAG00000021756, ENSG00000009724, ENSMUSG00000028979, ENSCAFG00845003035, ENSBTAG00000012808, ENSMMUG00000007459
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.